Brief: India's Marksans Pharma March-Qtr Profit Rises
29/05/2019 08:50
May 29 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARCH QUARTER CONSOL PROFIT 98.5 MILLION RUPEES VERSUS
LOSS OF
64.8 MILLION RUPEES YEAR AGO
* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.47 BILLION
RUPEES
VERSUS 1.99 BILLION RUPEES YEAR AGO
Source: http://bit.ly/2EDB3pm
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg